FIELD: medicine.
SUBSTANCE: invention relates to a compound presented by chemical formula 1, as well as to pharmaceutical compositions based thereon.
formula 1.
EFFECT: obtaining novel compounds which can be used for preventing or treating diseases, associated with sodium ion channel blocker.
12 cl, 5 tbl, 154 ex
Title | Year | Author | Number |
---|---|---|---|
2-CYANOPYRIMIDINE-4-YL CARBAMATE, OR A UREA DERIVATIVE, OR ITS SALT AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM | 2019 |
|
RU2788740C2 |
NEW PHTHALAZINE DERIVATIVES AND ITS PRODUCTION PROCESS | 2014 |
|
RU2636585C2 |
HETEROARYL DERIVATIVE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, A METHOD FOR PRODUCTION THEREOF AND A PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH PI3 KINASES, CONTAINING SAID ACTIVE SUBSTANCE | 2016 |
|
RU2719367C2 |
DIAMINOPYRIMIDINE DERIVATIVES AND METHODS FOR PRODUCTION THEREOF | 2012 |
|
RU2587981C2 |
DIAMINOPYRIMIDINE DERIVATIVES AND METHODS FOR PRODUCTION THEREOF | 2012 |
|
RU2587493C2 |
NEW COMPOUND, METHOD OF ITS PREPARATION AND USE | 2021 |
|
RU2814103C1 |
SODIUM CHANNEL BLOCKERS, PREPARATION METHOD THEREOF AND USE THEREOF | 2013 |
|
RU2645711C2 |
PYRROLOTRIAZINE DERIVATIVES AS KINASE INHIBITOR | 2018 |
|
RU2726632C1 |
NOVEL HETEROCYCLIC COMPOUND, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 2018 |
|
RU2733384C1 |
INDOLE COMPOUNDS AS CELL NECROSIS INHIBITORS | 2008 |
|
RU2477282C2 |
Authors
Dates
2019-11-08—Published
2016-11-11—Filed